EGF-R Positive Non-Small Cell Lung Cancer Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis
CNS MetastasesEGF-R Positive Non-Small Cell Lung Cancer
Tang-Du Hospital30 enrolled1 locationNCT06352502
Recruiting
Not Applicable
A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases
Non-small Cell Lung CancerNSCLCBrain Metastases+2 more
Hadassah Medical Organization162 enrolled1 locationNCT05033691